News Releases

Barclays Capital, the investment banking division of Barclays Bank PLC, is pleased to announce the appointment of Nicholas Moreira as a Managing Director and Head of Emerging Markets Equity Derivatives Trading effective 20 February 2007.  Based in London, Moreira will report to Dixit Joshi, Head of Equity Derivatives. 

Moreira joins Barclays Capital from Credit Suisse where, most recently, he was head of European derivatives trading. During his 15 year career at Credit Suisse, Moreira held a number of positions including heading the European equity proprietary trading group and head of global emerging markets equity-linked financing.

Over the past two years Barclays Capital has substantially expanded its emerging markets franchise and the firm now has a presence in 15 EM countries covering over 60 markets. Moreira will have responsibility for equity derivatives trading across all emerging markets including Russia, Turkey, Eastern Europe, Middle East, Africa and Latin America.

Commenting on the appointment, Joshi said, “Our growth momentum in equity derivatives over the past year has been phenomenal.  Nicholas brings deep expertise from a long career in emerging markets that will accelerate our ongoing build-out of this business.”

Other recent hires across equity derivatives include:

Avinash Shown-Keen joins on 7 May 2007 as a Director and Emerging Markets Equity Derivatives Trader based in London. He joins from Dresdner Kleinwort Wasserstein.

Nicolas Vong joined on 5 February 2007 as a Director and Head of Corporate Equity Derivatives, Asia Pacific based in Hong Kong. He joined from Merrill Lynch.

David Luk joined on 29 January 2007 as an Associate Director and Equity Derivatives Trader based in Hong Kong. He joined from Morgan Stanley.

Jan-Hendrik Petersen joined on 1 January 2007 as an Associate Director and Emerging Market Equity Derivatives Trader based in London. He joined from Dresdner Kleinwort Wasserstein.

For further information, please contact:

Nathaly Turner, Barclays Capital Communications, + 44 (0)20 7773 4171

Notes to editors:

About Barclays Capital Equity Derivatives Business

After the sale of the cash equity business of BZW to CSFB in 1997, Barclays Capital retained a small equity franchise which focused on providing direct market access for clients to the world’s main stock exchanges, convertible bond issuance, equity derivatives and prime brokerage.   Barclays Capital has invested significantly in its equity derivatives franchise and is now active across the full spectrum of equity derivatives instruments from market access trades and single stock options to complex exotic and multi-asset class (hybrid) structures.  Market coverage extends to all major equity indices along with the more liquid single stocks and an increasing presence in new and emerging markets.

In November 2006 Barclays Capital was named ‘US Equity Derivatives House of the Year’ by Derivatives Week.

About Barclays Capital
Barclays Capital is the investment banking division of Barclays Bank PLC which has an AA long-term credit rating and a balance sheet of over £986 billion. With a distinctive business model, Barclays Capital provides large corporate, government and institutional clients with solutions to their financing and risk management needs.  Barclays Capital has offices in 26 countries, employs over 10,500 people and has the global reach and distribution power to meet the needs of issuers and investors worldwide.

Barclays Capital - the investment banking division of Barclays Bank PLC. Registered in England 1026167. Registered office 1 Churchill Place, London, E14 5HP. Authorised and regulated by the Financial Services Authority and a member of the London Stock Exchange.